Toxicity and early outcomes of regorafenib in multiply pre-treated metastatic colorectal adenocarcinoma-experience from a tertiary cancer centre in India

DOI: 10.3978/j.issn.2305-5839.2016.02.05

Keywords: Regorafenib, metastatic colorectal cancers (mCRC), handfoot syndrome (HFS), hypertension

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text